Conmed (CNMD) Total Non-Current Liabilities (2010 - 2026)

Conmed's Total Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $1.2 billion for Q1 2026.

• Quarterly Total Non-Current Liabilities fell 0.83% year-over-year to $1.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 billion (down 0.83% YoY) and the FY2025 annual result came in at $1.2 billion, down 2.26% from the prior year.
• Total Non-Current Liabilities was $1.2 billion for Q1 2026 at Conmed, roughly flat from $1.2 billion in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $1.4 billion in Q2 2023 and bottomed at $954.4 million in Q1 2022.
• A 5-year average of $1.3 billion and a median of $1.3 billion in 2022 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2023 — Total Non-Current Liabilities soared 44.76% — and 2025, when it dropped 7.5%.
• Conmed's Total Non-Current Liabilities stood at $1.3 billion in 2022, then dropped by 0.27% to $1.3 billion in 2023, then fell by 6.51% to $1.3 billion in 2024, then declined by 2.26% to $1.2 billion in 2025, then increased by 0.44% to $1.2 billion in 2026.
• Business Quant data shows CNMD's Total Non-Current Liabilities at $1.2 billion in Q1 2026, $1.2 billion in Q4 2025, and $1.2 billion in Q3 2025.